Results
1 -
10 of
115Efficacy of a neoadjuvant gonadotropin-releasing hormone antagonist plus low-dose estramustine phosphate in high-risk prostate cancer: a single-center study, International Urology and Nephrology New Paradigms in the Management of Hormone Refractory Disease, Management of Prostate Cancer A reexamination of PSC 833 (Valspodar) as a cytotoxic agent and in combination with anticancer agents, Cancer Chemotherapy and Pharmacology Impact of PSA flare-up in patients with hormone-refractory prostate cancer undergoing chemotherapy, International Urology and Nephrology Estramustine and Prednimustine, Cancer of the Prostate and Kidney Cytotoxicity of a Steroid-Linked Mustard (Estramustine) through Non-DNA Targets, Cancer Chemotherapy and Selective Drug Development Estramustine revisited, Concepts, Mechanisms, and New Targets for Chemotherapy The Use of Fluorescent Probes in Characterizing Drug Resistance in Cultured Cells, Analytical Use of Fluorescent Probes in Oncology